Skip to main content

Table 2 Response in 33 Assessable Patients

From: Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer

Response

All Patients

 

No.

%

Complete response

1

3

Partial response

7

21.2

Stable disease

23

69.7

Progressive disease

2

6.1

Total

33

100

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us